menu

The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

In 2020 alone, it’s estimated more than 191,000 new cases of prostate cancer were diagnosed in the U.S. Learn how the clinical landscape is evolving.

  • Sponsored by

  • Overview

    Prostate cancer is one of the most common cancers in men in the United States. In a program sponsored by Astellas and Pfizer, Drs. Maha Hussain and Christopher Evans discuss the history and how care is evolving for men with metastatic prostate cancer and non-metastatic castration-resistant prostate cancer.

    This program is intended for United States health care professionals only. Drs. Hussain and Evans have recevied compensation from Astellas and Pfizer for their time.

    074-0391-PM 

Schedule2 Dec 2021
Webpack App